Drug Regulatory Affairs and Approval Process

This quiz covers the regulatory affairs and approval process for drugs, including the roles of different regulatory agencies, the drug development process, and the various stages of clinical trials.

15 Questions Published

Questions

Question 1 Multiple Choice (Single Answer)

Which regulatory agency is responsible for drug regulation in the United States?

  1. Food and Drug Administration (FDA)
  2. Centers for Disease Control and Prevention (CDC)
  3. National Institutes of Health (NIH)
  4. Environmental Protection Agency (EPA)
Question 2 Multiple Choice (Single Answer)

What is the first stage of clinical trials?

  1. Phase I
  2. Phase II
  3. Phase III
  4. Phase IV
Question 3 Multiple Choice (Single Answer)

What is the purpose of a New Drug Application (NDA)?

  1. To request approval for a new drug
  2. To request approval for a new indication for an existing drug
  3. To request approval for a new formulation of an existing drug
  4. To request approval for a new dosage form of an existing drug
Question 4 Multiple Choice (Single Answer)

What is the purpose of a Biologics License Application (BLA)?

  1. To request approval for a new biologic drug
  2. To request approval for a new indication for an existing biologic drug
  3. To request approval for a new formulation of an existing biologic drug
  4. To request approval for a new dosage form of an existing biologic drug
Question 5 Multiple Choice (Single Answer)

What is the purpose of a Premarket Approval Application (PMA)?

  1. To request approval for a new medical device
  2. To request approval for a new indication for an existing medical device
  3. To request approval for a new formulation of an existing medical device
  4. To request approval for a new dosage form of an existing medical device
Question 6 Multiple Choice (Single Answer)

What is the purpose of an Investigational New Drug Application (IND)?

  1. To request permission to conduct clinical trials of a new drug
  2. To request permission to market a new drug
  3. To request permission to conduct preclinical studies of a new drug
  4. To request permission to manufacture a new drug
Question 7 Multiple Choice (Single Answer)

What is the purpose of a Clinical Trial Application (CTA)?

  1. To request permission to conduct clinical trials of a new drug in the European Union
  2. To request permission to market a new drug in the European Union
  3. To request permission to conduct preclinical studies of a new drug in the European Union
  4. To request permission to manufacture a new drug in the European Union
Question 8 Multiple Choice (Single Answer)

What is the purpose of a Marketing Authorization Application (MAA)?

  1. To request permission to market a new drug in the European Union
  2. To request permission to conduct clinical trials of a new drug in the European Union
  3. To request permission to conduct preclinical studies of a new drug in the European Union
  4. To request permission to manufacture a new drug in the European Union
Question 9 Multiple Choice (Single Answer)

What is the purpose of a New Chemical Entity (NCE)?

  1. A new drug that has never been marketed before
  2. A new drug that has been marketed before but has been reformulated
  3. A new drug that has been marketed before but has been given a new indication
  4. A new drug that has been marketed before but has been given a new dosage form
Question 10 Multiple Choice (Single Answer)

What is the purpose of a New Molecular Entity (NME)?

  1. A new drug that has never been marketed before
  2. A new drug that has been marketed before but has been reformulated
  3. A new drug that has been marketed before but has been given a new indication
  4. A new drug that has been marketed before but has been given a new dosage form
Question 11 Multiple Choice (Single Answer)

What is the purpose of a New Active Substance (NAS)?

  1. A new drug that has never been marketed before
  2. A new drug that has been marketed before but has been reformulated
  3. A new drug that has been marketed before but has been given a new indication
  4. A new drug that has been marketed before but has been given a new dosage form
Question 12 Multiple Choice (Single Answer)

What is the purpose of a New Biological Entity (NBE)?

  1. A new biologic drug that has never been marketed before
  2. A new biologic drug that has been marketed before but has been reformulated
  3. A new biologic drug that has been marketed before but has been given a new indication
  4. A new biologic drug that has been marketed before but has been given a new dosage form
Question 13 Multiple Choice (Single Answer)

What is the purpose of a New Therapeutic Entity (NTE)?

  1. A new drug that has never been marketed before
  2. A new drug that has been marketed before but has been reformulated
  3. A new drug that has been marketed before but has been given a new indication
  4. A new drug that has been marketed before but has been given a new dosage form
Question 14 Multiple Choice (Single Answer)

What is the purpose of a New Chemical Entity (NCE)?

  1. A new drug that has never been marketed before
  2. A new drug that has been marketed before but has been reformulated
  3. A new drug that has been marketed before but has been given a new indication
  4. A new drug that has been marketed before but has been given a new dosage form
Question 15 Multiple Choice (Single Answer)

What is the purpose of a New Molecular Entity (NME)?

  1. A new drug that has never been marketed before
  2. A new drug that has been marketed before but has been reformulated
  3. A new drug that has been marketed before but has been given a new indication
  4. A new drug that has been marketed before but has been given a new dosage form